Structure activity relationship of xanthones for inhibition of Cyclin Dependent Kinase 4 from mangosteen (Garcinia mangostana L.).

CDK4 cancer garcinia mangostana gartanin mangosteen mangostin xanthone

Journal

International journal of nutrition
ISSN: 2379-7835
Titre abrégé: Int J Nutr
Pays: United States
ID NLM: 101722026

Informations de publication

Date de publication:
2019
Historique:
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 1 8 2019
Statut: ppublish

Résumé

The mangosteen fruit is a popular Southeast Asian fruit consumed for centuries. There have been a variety of xanthones isolated from the fruit, bark, roots and leaves with each having unique chemical and physical properties. Previously, the most abundant xanthone α-mangostin has been shown to inhibit CDK4. Herein we describe the role of selected xanthones from the mangosteen inhibiting CDK4. The evidence we provide here is that key functional groups are required to inhibit the CDK4 protein to prevent the phosphorylation of downstream targets critical to inhibiting uncontrolled cell cycle progression. To define the properties of xanthones for inhibiting CDK4 we utilized a cell free biochemical assay to identify inhibitors of CDK4. The following xanthones were used for the analysis: α-mangostin, β-mangostin, γ-mangostin, gartanin, 8-desoxygartanin, garcinone C and garcinone D, 9-hydroxycalabaxanthone, and 3-isomangostin These results further substantiate the unique pharmacological properties of individual xanthones and how a mixture of xanthones may be responsible for a multi-targeted effect in cell based pharmacology systems.

Identifiants

pubmed: 31363494
pmc: PMC6667231
mid: NIHMS1040614

Types de publication

Journal Article

Langues

eng

Pagination

38-45

Subventions

Organisme : NCI NIH HHS
ID : R37 CA227101
Pays : United States

Déclaration de conflit d'intérêts

Conflicts of interest The authors do not declare any conflicts of interest.

Références

Chem Pharm Bull (Tokyo). 2006 Mar;54(3):301-5
pubmed: 16508181
Food Chem Toxicol. 2008 Oct;46(10):3227-39
pubmed: 18725264
Phytother Res. 2009 Aug;23(8):1047-65
pubmed: 19172667
Int J Mol Sci. 2008 Mar;9(3):355-70
pubmed: 19325754
Curr Mol Med. 2011 Nov;11(8):666-77
pubmed: 21902651
Carcinogenesis. 2012 Feb;33(2):413-9
pubmed: 22159229
Curr Drug Targets. 2012 Dec;13(14):1698-704
pubmed: 23140281
Front Pharmacol. 2013 Jun 26;4:80
pubmed: 23805102
Nutr Res. 2014 Apr;34(4):336-45
pubmed: 24774070
Biochem Biophys Res Commun. 2014 Oct 10;453(1):75-80
pubmed: 25261723
Clin Cancer Res. 2015 Jul 1;21(13):2905-10
pubmed: 25941111
Clin Breast Cancer. 2016 Feb;16(1):8-17
pubmed: 26303211
Discov Med. 2016 Jan;21(113):65-74
pubmed: 26896604
Mol Nutr Food Res. 2016 Jun;60(6):1458-69
pubmed: 27019217
J Ethnopharmacol. 2017 Feb 23;198:302-312
pubmed: 28108382
Nat Rev Cancer. 2017 Jan 27;17(2):93-115
pubmed: 28127048
Pharmacol Ther. 2017 May;173:83-105
pubmed: 28174091
Food Chem Toxicol. 2017 Nov;109(Pt 1):102-122
pubmed: 28842267
Trends Cell Biol. 2018 Nov;28(11):911-925
pubmed: 30061045
Science. 1996 Dec 6;274(5293):1672-7
pubmed: 8939849

Auteurs

Bhaskar Vemu (B)

University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice.

Mirielle C Nauman (MC)

University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice.

Jacob P Veenstra (JP)

University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice.

Jeremy J Johnson (JJ)

University of Illinois at Chicago, College of Pharmacy, Department of Pharmacy Practice.

Classifications MeSH